| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund IDCW Payout Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.88 |
| Derivatives/Mutual Fund/ETF |
1.39 |
| Equity |
96.58 |
| Trep |
1.15 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
37.77% |
| Top 10 Holdings |
61.85% |
| Top 25 Holdings |
91.50% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
69.24 |
| Healthcare |
18.36 |
| Food Beverage & Tobacco |
2.66 |
| Cash |
2.03 |
| Consumer Durables |
2.02 |
| Chemicals |
2.01 |
| Debt MF |
1.39 |
| Miscellaneous |
0.96 |
| Technology |
0.83 |
| Fertilisers |
0.27 |
| Electricals |
0.23 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
6.37 |
| PE Ratio |
52.78 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Divis Laboratories Ltd. |
9.67 |
| Sun Pharmaceutical Industries Ltd. |
8.87 |
| PIRAMAL PHARMA LIMITED |
6.60 |
| Apollo Hospitals Enterprises Ltd. |
6.50 |
| Aurobindo Pharma Ltd. |
6.13 |
| RUBICON RESEARCH LIMITED |
6.01 |
| Torrent Pharmaceuticals Ltd. |
5.48 |
| Neuland Laboratories Limited. |
4.42 |
| Emcure Pharmaceuticals Limited |
4.37 |
| Max Healthcare Institute Limited |
3.80 |
| Fortis Healthcare Ltd |
3.01 |
| Zydus Wellness Limited |
2.66 |
| Laurus Labs Limited |
2.41 |
| Ipca Laboratories Ltd. |
2.34 |
| Vijaya Diagnostic Centre Limited |
2.20 |
| SENORES PHARMACEUTICALS LIMITED |
2.11 |
| Shaily Engineering Plastics Ltd. |
2.02 |
| Navin Fluorine International Limited |
2.01 |
| Dr. Lal Pathlabs Limited |
1.78 |
| Sanofi Consumer Healthcare India Limited |
1.70 |
| GlaxoSmithkline Pharmaceuticals Ltd. |
1.68 |
| Glenmark Pharmaceuticals ltd |
1.64 |
| Bajaj Finserv Money Market Fund-Direct Plan-Growth |
1.39 |
| Dr. Reddys Laboratories Ltd. |
1.37 |
| Zydus Lifesciences Limited |
1.33 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
